WellSIM Biotech

Developer of liquid biopsy biotechnology designed for non-invasive cancer testing. The company’s biotechnology conducts biopsy through precise stabilization, enrichment, isolation, and analytical interrogation of circulating extracellular vesicles and exosomes from cell-free specimens such as urine, saliva, and plasma, enabling healthcare professionals to perform therapeutic and clinical diagnostics.